Richard I. Fisher, MD
- President and CEO, Fox Chase Cancer Center
- Cancer Center Director
- Senior Associate Dean,
Temple University School of Medicine
Dr. Fisher holds a set of vital leadership roles at Fox Chase Cancer Center of the Temple University Health System, and at Temple University School of Medicine
At Fox Chase Cancer Center, Fisher is the President, Chief Executive Officer, and Cancer Center Director. His responsibilities include overseeing and leading the seven clinical department chairs at the Center. At Temple University School of Medicine, Fisher is senior associate dean for cancer programs, reporting to the dean of the school of medicine.
Fisher majored in chemistry and physics at Harvard University before being awarded his medical degree, cum laude, from Harvard Medical School in 1970. From 1970-1972, he was an intern and resident at Massachusetts General Hospital. Highlights among his many subsequent clinical and scientific postings include: immunology and oncology fellowships at the National Cancer Institute, Bethesda, MD, from 1972-1975; director of the Cardinal Bernadin Cancer Center at Loyola University Stritch School of Medicine from 1984-2001; director of the Hematology/Oncology Division at the University of Rochester School of Medicine and Dentistry (URSMD) from 2001-2009; and senior associate dean for clinical affairs and director of the Rochester Medical Faculty Group at URSMD from 2008-2011. He also serves as principal investigator for a Lymphoma SPORE (Specialized Program of Research Excellence) grant.
Fisher has also held a number of important leadership positions in the oncology community at the national level over the span of his career. Highlights among these include: Chair of the lymphoma committee of the Southwest Oncology Group (SWOG) from 1985-present; deputy group chair of SWOG from 2005-present; and chair of the Lymphoma Research Foundation Scientific Advisory Board from 2008-2010. Other roles, honors, and awards include: Member of the Board of Scientific Advisors for the V Foundation from 2003-present; member of the National Cancer Institute (NCI) lymphoma steering committee from 2009-present; and chair of the NCI Specialized Programs of Research Excellence (SPORE) review committee in 2010.
Previously, Fisher was vice president for strategic and program development at the University of Rochester Medical Center, where he was also the Samuel E. Durand Professor of Medicine. For eleven years, Fisher served as director of the James P. Wilmot Cancer Center at the University of Rochester School of Medicine and Dentistry and director of cancer services for the Strong Health System in Rochester, NY.